Invivyd
Biologics & Biosimilars · Infectious Disease Therapeutics

Invivyd: Ownership & structure

Invivyd operates through 2 legal entities in 1 country.

Data updated Nov 20, 2026 · Back to the company report

Owners & entities

Invivyd operates through 2 legal entities in 1 country.

Legal entities2 in 1 country
Invivyd, Inc.
operator · US EIN 851403134
US
Adagio Therapeutics, Inc.
operator
US
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $531k (5 people) in the last 12 months.

Sold · Chief Legal Officer, Secretary
30,706 shares at $0.84 · Aug 2026
$26k
Sold · Chief Commercial Officer
18,425 shares at $0.84 · Aug 2026
$15k
Sold · Chief Human Resources Officer
18,425 shares at $0.84 · Aug 2026
$15k
Sold · Chief Financial Officer
18,425 shares at $0.84 · Aug 2026
$15k
Sold · Chief Scientific Officer
17,043 shares at $0.84 · Aug 2026
$14k
Sold · Chief Legal Officer, Secretary
37,256 shares at $0.72 · Aug 2026
$27k
Sold · Chief Commercial Officer
22,355 shares at $0.72 · Aug 2026
$16k
Sold · Chief Human Resources Officer
22,355 shares at $0.72 · Aug 2026
$16k
Sold · Chief Financial Officer
22,355 shares at $0.72 · Aug 2026
$16k
Sold · Chief Scientific Officer
20,679 shares at $0.72 · Aug 2026
$15k
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
Premji InvestVia a fund
107 portfolio companies: Writer, Zuora, Yapstone and 104 more
131 portfolio companies: Veracyte, UpDoc, Zura Bio and 128 more
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more